Body Weight Reduction with Anti-Obesity Medication? Drug Therapy of Overweight and Obesity

被引：1
|
作者：
Smollich, Martin [1 ,2 ]
机构：
[1] Arzneimittelkommiss Deutsch Arzteschaft AkdA, Berlin, Germany
[2] Univ Klinikum Schleswig Holstein, Inst Ernahrungsmed, Arbeitsgrp Pharmakonutrit, Lubeck, Germany
来源：
AKTUELLE ERNAHRUNGSMEDIZIN | 2021年 / 46卷 / 01期
关键词：
amphetamine; liraglutide; naltrexone/bupropion; obesity; orlistat;
D O I：
10.1055/a-1118-2562
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：41 / 55
页数：15
相关论文
共 50 条
  • [11] Memantine: A new anti-obesity drug
    Holt, RIG
    [J]. DIABETES OBESITY & METABOLISM, 2005, 7 (05): : 620 - 620
  • [12] Association between shared medical appointments and weight loss outcomes and anti-obesity medication use in patients with obesity
    Shibuya, Kelly
    Ji, Xinge
    Pfoh, Elizabeth R.
    Milinovich, Alex
    Weng, Wayne
    Bauman, Janine
    Ganguly, Rahul
    Misra-Hebert, Anita D.
    Hobbs, Todd M.
    Kattan, Michael W.
    Pantalone, Kevin M.
    Ramasamy, Abhilasha
    Burguera, Bartolome
    [J]. OBESITY SCIENCE & PRACTICE, 2020, 6 (03): : 247 - 254
  • [13] Impact of anti-obesity medication initiation and duration on weight loss in a comprehensive weight loss programme
    Safavi, R.
    Lih, A.
    Kirkpatrick, S.
    Haller, S.
    Bailony, M. R.
    [J]. OBESITY SCIENCE & PRACTICE, 2019, 5 (05): : 468 - 478
  • [14] Natural products in anti-obesity therapy
    Vermaak, Ilze
    Viljoen, Alvaro M.
    Hamman, Josias H.
    [J]. NATURAL PRODUCT REPORTS, 2011, 28 (09) : 1493 - 1533
  • [15] Natural Products in Anti-Obesity Therapy
    Conforti, Filomena
    Pan, Min-Hsiung
    [J]. MOLECULES, 2016, 21 (12):
  • [16] The association between previous use of anti-obesity medication and semaglutide weight loss outcomes
    Ghusn, Wissam
    Fansa, Sima
    Anazco, Diego
    Tama, Elif
    Cifuentes, Lizeth
    Gala, Khushboo
    de la Rosa, Alan
    Sacoto, Daniel
    Campos, Alejandro
    Feris, Fauzi
    Hurtado, Daniela
    Acosta, Andres
    [J]. DIABETES OBESITY & METABOLISM, 2024, 26 (06): : 2167 - 2175
  • [17] Simulating the Fiscal Impact of Anti-Obesity Medications as an Obesity Reduction Strategy
    Kabiri, Mina
    Ward, Alison Sexton
    Ramasamy, Abhilasha
    Kee, Rebecca
    Ganguly, Rahul
    Smolarz, Brian Gabriel
    Zvenyach, Tracy
    Baumgardner, James R.
    Goldman, Dana P.
    [J]. INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2021, 58
  • [18] The effects of anti-obesity drug treatment on fibromyalgia
    Tamer, N
    Katyrcy, S
    Akkus, S
    Akta, K
    Tunç, E
    Özcankaya, R
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 504 - 504
  • [19] Anti-obesity drug discovery: advances and challenges
    Mueller, Timo D.
    Blueher, Matthias
    Tschoep, Matthias H.
    DiMarchi, Richard D.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (03) : 201 - 223
  • [20] Niclosamide as an anti-obesity drug: an experimental study
    Al-Gareeb, Ali I.
    Aljubory, Khalid D.
    Alkuraishy, Hayder M.
    [J]. EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2017, 22 (02) : 339 - 344
12345